Solution structure of the HIV-2 TAR-argininamide complex

Journal of Molecular Biology

Volumn 267, Issue 3, 1997, Pages 624-639

  Brodsky, Alexander S ^a   Williamson, James R ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

NMR spectroscopy; RNA structure; RNA protein interactions; TAR RNA

Indexed keywords

AMIDE; ARGININE DERIVATIVE; RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; COMPLEX FORMATION; HUMAN IMMUNODEFICIENCY VIRUS 2; HYDROGEN BOND; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA STRUCTURE;

EID: 0031552350     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0879     Document Type: Article

References (59)

1. Aboul-ela F., Karn J., Varani G. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253:1995;313-332.
2. Allain F. H.-T., Gubser C. C., Howe P. W. A., Nagai K., Neuhaus D., Varani G. Specificity of ribonucleoprotein interaction determined by RNA folding during complex formation. Nature. 380:1996;646-650.
3. Batey R. T., Battiste J. L., Williamson J. R. Preparation of isotopically enriched RNAs for heteronuclear NMR. Methods Enzymol. 261:1995;300-322.
4. Battiste J. L., Mao H., Rao N. S., Tan R., Muhandiram D. R., Kay L. E., Frankel A. D., Williamson J. R. α-Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science. 273:1996;1547-1551.
5. Berman H. M., Olson W. K., Beveridge D. L., Westbrook J., Gelbin A., Demeny T., Hsieh S.-H., Srinivasan A. R., Schneider B. The nucleic acid database: a guide to the use of a relational database of nucleic acid crystal structures. Biophys. J. 63:1992;751-759.
6. Brunger A. T. X-PLOR User Manual. 1992;Yale University, New Haven.
7. Calnan B. J., Tidor B., Biancalana S., Hudson D., Frankel A. D. Arginine-mediated RNA recognition: the arginine fork. Science. 252:1991;1167-1171.
8. Chang Y., Jeang K. The basic RNA-binding domain of HIV-2 Tat contributes to preferential trans-activation of a TAR2-containing LTR. Nucl. Acids Res. 20:1992;5465-5472.
9. Churcher M. J., Lamont C., Hamy F., Dingwall C., Green S. M., Lowe A. D., Butler P. J. G., Gait M. J., Karn J. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 Tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region. J. Mol. Biol. 230:1993;90-110.
10. Colvin R. A., White S. W., Garcia-Bianco M. A., Hoffman D. W. Structural features of an RNA containing the CUGGGA loop of the human immunodeficiency virus type 1 trans -activating response element. Biochemistry. 32:1993;1105-1112.
11. Cordingly M. G., LaFemina R. L., Callahan P. L., Condra J. H., Sardana V. V., Graham D. J., Nguyen T. M., LeGrow K., Gotlib L., Schlabach A. J., Colonno R. J. Sequence-specific interaction of tat protein and tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc. Natl Acad. Sci. USA. 87:1990;8985-8989.
12. Delaglio F., Grzesiek S., Vuister G., Zu G., Pfeiffer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:1995;277-293.
13. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skiner M. A., Valrio R. Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl Acad. Sci. USA. 86:1989;6925-6929.
14. Dingwall C., Ernberg I., Gait M. J., Green S. M., Heaphy S., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:1990;4145-4153.
15. Draper D. Protein-RNA recognition. Annu. Rev. Biochem. 64:1995;593-620.
16. Elrod-Erickson M., Rould M. A., Nekludova L., Pabo C. O. Zif268 protein-DNA complex refined at 1.6 Å: a model system for understanding zinc finger-DNA interactions. Structure. 4:1996;1171-1180.
17. Fan P., Suri A. K., Fiala R., Live D., Patel D. J. Molecular recognition in the FMN-RNA aptamer complex. J. Mol. Biol. 258:1996;480-500.
18. Frankel A. D. Activation of HIV transcription by Tat. Curr. Opin. Genet. Dev. 2:1992;293-298.
19. Garrett D. S., Powers R., Gronenborn A. M., Clore G. M. A common sense approach to peak picking in two-, three- and four-dimensional spectra using automatic computer analysis of contour programs. J. Mag. Reson. 95:1991;214-220.
20. Gelbin A., Schneider B., Clowney L., Hsieh S.-H., Olsen W. K., Berman H. M. Geometric parameters in nucleic acids: sugar and phosphate constituents. J. Am. Chem. Soc. 118:1996;519-529.
21. Green H., Freeman R. Band-selective radiofrequency pulses. J. Mag. Reson. 93:1991;93-141.
22. Hamy F., Asseline U., Grasby J., Iwai S., Pritchard C., Slim G., Butler P. J. G., Karn J., Gait M. J. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. J. Mol. Biol. 230:1993;111-123.
23. 31P) and two-dimensional hetero TOCSY. J. Am. Chem. Soc. 116:1994;4983-4984.
24. Jaeger J., Tinoco I. An NMR study of the HIV-1 TAR element hairpin. Biochemistry. 32:1993;12522-12530.
25. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
26. Jucker F. M., Pardi A. Solution structure of the CUUG hairpin loop: a novel RNA tetraloop motif. Biochemistry. 34:1995;14416-14427.
27. Lippens G., Dhalluin C., Wieruszeki J.-M. Use of a water flip-back pulse in the homonuclear NOESY experiment. J. Biomol. NMR. 5:1995;327-331.
28. Long K. S., Crothers D. M. Interaction of human immunodeficiency virus type 1 tat-derived peptides with TAR RNA. Biochemistry. 34:1995;8885-8895.
29. Macaya R., Wang E., Schultze P., Skelnár V., Feigon J. Proton nuclear magnetic resonance assignments and structural characterization of an intramolecular DNA triplex. J. Mol. Biol. 225:1992;755-773.
30. 31P experiment: sequential through-bond correlation of ribose protons and intervening phosphorous along the RNA oligonucleotide backbone. J. Am. Chem. Soc. 116:1994;6472-6473.
31. Milligan J. F., Groebe D. R., Witherell G. W., Uhlenbeck O. C. Oligoribonucleotide synthesis using T7 RNA-polymerase and synthetic DNA templates. Nucl. Acids Res. 15:1987;8783-8798.
32. Mori S., Abeygunawardana C., Johnson M. O., Zijl P. C. M. v. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Mag. Res. ser. B. 108:1995;94-98.
33. 13C-labeled RNAs. J. Am. Chem. Soc. 114:1992;9202-9303.
34. Oubridge C., Ito N., Evans P. R., Teo C.-H., Nagai K. Crystal structure at 1.92 Å resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature. 372:1994;432-438.
35. Piotto M., Saudek V., Skelnár V. Gradient tailored excitation for single quantum NMR spectroscopy of aqueous solution. J. Biomol. NMR. 2:1992;661-665.
36. Pritchard C. E., Grasby J. A., Hamy F., Zacharek A. M., Singh M., Karn J., Gait M. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins. Nucl. Acids Res. 22:1994;2592-2600.
37. Puglisi J. D., Tan R., Calnan B. J., Frankel A. D., Williamson J. R. Conformations of the TAR RNA-arginine complex by NMR spectroscopy. Science. 257:1992;76-80.
38. Puglisi J. D., Chen L., Frankel A. D., Williamson J. R. Role of RNA structure in arginine recognition of TAR RNA. Proc. Natl Sci. USA. 90:1993;3680-3684.
39. Puglisi J. D., Chen L., Blanchard S., Frankel A. D. Solution structure of a bovine immunodeficiency virus tat TAR RNA-peptide complex. Science. 270:1995;1200-1203.
40. Roberts J. D., Ladner J. E., Finch J. T., Rhodes D., Brown R. S., Clark B. F. C., Klug A. Structure of yeast phenylalanine tRNA at 3 Å resolution. Nature. 250:1974;546-551.
41. Roy S., Delling U., Chen C.-H., Rosen C. A., Sonenberg N. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans -activation. Genes Develop. 4:1990a;1365-1373.
42. Roy S., Parkin N. T., Rosen C. A., Itovitch J., Sonenberg N. Structural requirements for trans -activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by Tat: importance of base-pairing, loop sequence and bulges in the Tat-responsive sequence. J. Virol. 64:1990b;1402-1406.
43. Shaka A. J., Keeler J., Freeman R. Evaluation of a new broadband decoupling sequence: WALTZ-16. J. Mag. Reson. 53:1983;313-340.
44. 1H resonances in oligonucleotides by two-dimensional NMR spectroscopy. FEBS Letters. 208:1986;94-98.
45. Sumner-Smith M., Roy S., Barnett R., Reid S. L., Kuperman R., Delling U., Sonenberg N. Critical features in trans -acting-responsive RNA are required for interaction of human immunodeficiency virus type 1 Tat protein. J. Virol. 65:1991;5196-5202.
46. Tao J., Frankel A. D. Specific binding of arginine to TAR RNA. Proc. Natl Acad. Sci. USA. 89:1992;2723-2726.
47. Tao J., Frankel A. D. Electrostatic interactions modulate the RNA-binding and transactivation specificites of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins. Proc. Natl Acad. Sci. USA. 90:1993;1571-1575.
48. Tao J., Frankel A. D. Arginine-binding RNAs resembling TAR identified by in vitro selection. Biochemistry. 35:1996;2229-2238.
49. Valegard K., Murray J. B., Stockley P. G., Stonehouse N. J., Liljas L. Crystal structure of an RNA bacteriophage coat protein-operator complex. Nature. 371:1994;623-626.
50. Varani G., Tinoco I. J. RNA structure and NMR spectroscopy. Quart. Rev. Biophys. 24:1991;479-532.
51. Varani G., Aboul-ela F., Allain F. H.-T. NMR investigation of RNA structure. Prog. Nucl. Magn. Reson. Spectrosc. 29:1996;51-127.
52. 13C-separated HMQC-NOESY-HMQC spectra using pulsed field gradients. J. Mag. Res., ser. B. 101:1993;210-213.
53. Weeks K. M., Crothers D. M. RNA recognition by Tat-derived peptides: interaction in the major groove. Cell. 66:1991;577-588.
54. Weeks K. M., Crothers D. M. RNA binding assays for Tat-derived peptides: implications for specificity. Biochemistry. 31:1992;10281-10287.
55. Weeks K. M., Ampe C., Schultz S. C., Steitz T. A., Crothers D. M. Fragments of the HIV-1 tat protein specifically bind TAR RNA. Science. 249:1990;1281-1285.
56. Weiner S. J., Kollman P. A., Nguyen D. T., Case D. A. An all atom forcefield for simulations of proteins and nucleic acid. J. Comp. Chem. 7:1986;230-252.
57. Yang Y., Kochoyan M., Burgstaller P., Westhof E., Famulok M. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy. Science. 272:1996;1343-1347.
58. Ye X., Kumar R. A., Patel D. J. Molecular recognition in the bovine immunodeficiency virus tat peptide TAR RNA complex. Chem. Biol. 2:1995;827-840.
59. Zacharias M., Hagerman P. J. The bend in RNA created by the trans -activating response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide. Proc. Natl Acad. Sci. USA. 92:1995;6052-6056.